SThree (LON:STEM – Get Free Report) issued its quarterly earnings data on Tuesday. The company reported GBX 37.40 ($0.47) EPS for the quarter, Digital Look Earnings reports. SThree had a net margin of 3.53% and a return on equity of 26.60%.
SThree Stock Down 1.5 %
Shares of SThree stock traded down GBX 4 ($0.05) during trading hours on Thursday, reaching GBX 260 ($3.24). The company’s stock had a trading volume of 624,886 shares, compared to its average volume of 385,407. SThree has a one year low of GBX 221.50 ($2.76) and a one year high of GBX 457.50 ($5.70). The stock’s fifty day simple moving average is GBX 301.47 and its two-hundred day simple moving average is GBX 358.53. The company has a market capitalization of £345.54 million, a P/E ratio of 619.05, a P/E/G ratio of 0.75 and a beta of 0.98. The company has a debt-to-equity ratio of 11.91, a quick ratio of 1.69 and a current ratio of 1.89.
Insider Activity at SThree
In related news, insider Andrew Beach acquired 9,436 shares of the company’s stock in a transaction dated Tuesday, December 17th. The stock was purchased at an average price of GBX 265 ($3.30) per share, with a total value of £25,005.40 ($31,132.22). Also, insider Elaine ODonnell bought 5,500 shares of the stock in a transaction dated Thursday, November 14th. The stock was purchased at an average price of GBX 344 ($4.28) per share, with a total value of £18,920 ($23,555.78). Over the last quarter, insiders have bought 15,022 shares of company stock worth $4,419,450. Insiders own 6.23% of the company’s stock.
Analyst Ratings Changes
Check Out Our Latest Stock Report on STEM
About SThree
SThree plc brings skilled people together to build the future. We are the only global specialist talent partner focused on roles in Science, Technology, Engineering and Mathematics (‘STEM’), providing permanent and flexible contract talent to a diverse base of over 7,200 clients across 11 countries. Our Group’s c.2,600 staff cover the Technology, Life Sciences and Engineering sectors.
Read More
- Five stocks we like better than SThree
- Manufacturing Stocks Investing
- Is Tonix Pharmaceuticals the Next Biotech Breakout?
- Market Cap Calculator: How to Calculate Market Cap
- DeepSeek Dip: Is the Nuclear Energy Sell-Off a Buying Opportunity
- Health Care Stocks Explained: Why You Might Want to Invest
- ASML: Strengths and Upside Remain Despite DeepSeek Worries
Receive News & Ratings for SThree Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SThree and related companies with MarketBeat.com's FREE daily email newsletter.